Dissolution rates of high energy sulfathiazole--povidone coprecipitates II: characterization of form of drug controlling its dissolution rate via solubility studies.
about
Haste Makes Waste: The Interplay Between Dissolution and Precipitation of Supersaturating FormulationsMicrobial transformations of natural antitumor agents: use of solubilizing agents to improve yields of hydroxylated ellipticinesUsing polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility.Application of pharmaceutical QbD for enhancement of the solubility and dissolution of a class II BCS drug using polymeric surfactants and crystallization inhibitors: development of controlled-release tablets.Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction.Solid dispersions of diflunisal-PVP: polymorphic and amorphous states of the drug.Inclusion complexation of artemisinin with alpha-, beta-, and gamma-cyclodextrins.QbD approach of rapid disintegrating tablets incorporating indomethacin solid dispersion.Cefuroxime axetil solid dispersions prepared using solution enhanced dispersion by supercritical fluids.Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.Dissolution rate enhancement, in vitro evaluation and investigation of drug release kinetics of chloramphenicol and sulphamethoxazole solid dispersions.
P2860
Q30378760-49E702FF-A5C4-4CD4-9310-3D86D6A4862EQ34046134-AE55E8B9-EB8E-478B-B176-D252B0578255Q37802897-634F8457-68EF-4AFF-A159-008136D89473Q38312135-83969A08-36F1-4B9E-A615-9C243DD22FCEQ42104195-8429058D-CD59-41CC-B519-9319D2CE08E4Q44084018-B8895E15-35B1-410F-9B39-F4A577612AD9Q44647907-F683CB96-A348-4C5E-9C35-B9B71C335EBBQ46671481-6E7278A5-3E3D-401D-A542-18E738D0D0D8Q46851055-C3922036-E628-4A05-AEA1-82F3EAB0925BQ47624194-A19BBE8B-0676-43B2-8B6F-3EE3AA5D7F7AQ51363069-17883E69-E8CD-4CE9-A873-474394155DA6
P2860
Dissolution rates of high energy sulfathiazole--povidone coprecipitates II: characterization of form of drug controlling its dissolution rate via solubility studies.
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年学术文章
@wuu
1976年学术文章
@zh
1976年学术文章
@zh-cn
1976年学术文章
@zh-hans
1976年学术文章
@zh-my
1976年学术文章
@zh-sg
1976年學術文章
@yue
1976年學術文章
@zh-hant
name
Dissolution rates of high ener ...... n rate via solubility studies.
@en
Dissolution rates of high ener ...... n rate via solubility studies.
@nl
type
label
Dissolution rates of high ener ...... n rate via solubility studies.
@en
Dissolution rates of high ener ...... n rate via solubility studies.
@nl
prefLabel
Dissolution rates of high ener ...... n rate via solubility studies.
@en
Dissolution rates of high ener ...... n rate via solubility studies.
@nl
P2093
P356
P1476
Dissolution rates of high ener ...... n rate via solubility studies.
@en
P2093
Higuchi WI
Simonelli AP
P304
P356
10.1002/JPS.2600650310
P407
P577
1976-03-01T00:00:00Z